A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation

Transplantation
S SuzukiK Chiba

Abstract

A new compound with an immunosuppressive property was purified from culture filtrates of Isaria sinclairii and was chemically modified to FTY720. Rat spleen cells incubated with FTY720 demonstrated features characteristic of apoptosis--such as the absence of surface microvilli, chromatin condensation, and the formation of apoptotic bodies--by electron microscopy, and genemic DNA fragmentation by agarose gel electrophoresis. When FTY720 was administered in liver-allografted rats at a dose of 0.5 mg/kg from day 1 to day 14 after transplantation, the recipients survived significantly longer than the control group. Pretransplant treatment with 5 mg/kg of FTY720 one day before and on the day of grafting induced a remarkable prolongation of recipient survival, and three of 10 recipients survived for longer than 50 days. Furthermore, administration of FTY720 at 5 mg/kg on days 3 and day 4 after grafting also prolonged survival. In canine kidney allografting, a pretransplant 2-day course of FTY720 at 5 mg/kg prolonged graft survival. Daily administration of FTY720 in combination with CsA resulted in a significant prolongation of graft survival in a synergistic manner. In addition, FTY720 appeared to be nontoxic in canine recipients. Th...Continue Reading

Citations

Aug 1, 2008·Inflammatory Bowel Diseases·Takayuki TomitaMamoru Watanabe
Jan 1, 1996·Transplant International : Official Journal of the European Society for Organ Transplantation·B D Kahan
Dec 14, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Constantin Bode, Markus H Gräler
Dec 14, 2004·Transplant International : Official Journal of the European Society for Organ Transplantation·Tomomi SuzukiSatoru Todo
Jul 22, 2005·Surgery Today·Kiminobu SugitoMasahiro Fukuzawa
May 15, 2012·Molecular Biology Reports·Jingyu JiangJianhua Zhou
Apr 25, 2012·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Qi ChengXiaoping Chen
Mar 12, 2011·Advances in Therapy·E Ann Yeh, B Weinstock-Guttman
Jun 20, 2013·Behavioural Brain Research·Fatemeh HemmatiAbolhassan Ahmadiani
Mar 26, 2004·Transplantation Proceedings·D DragunH H Neumayer
Mar 26, 2004·Transplantation Proceedings·H Furukawa, S Todo
Mar 26, 2004·Transplantation Proceedings·R Ferguson
Mar 26, 2004·Transplantation Proceedings·B D Kahan
Aug 29, 1998·Clinical Biochemistry·P Troncoso, B D Kahan
Dec 20, 2000·Transplantation Proceedings·R L Schmouder
Dec 20, 2000·Transplantation Proceedings·S C ChuehM K Lai
Mar 27, 2001·Transplantation Proceedings·S C ChuehM K Lai
May 30, 2001·Transplantation Proceedings·V QuesniauxH J Schuurman
Dec 26, 2001·Transplantation Proceedings·B D Kahan
Oct 8, 2003·Transplantation Proceedings·B D Kahan
Jun 24, 1998·Transplantation Proceedings·K YuzawaK Fukao
Sep 2, 1998·Transplantation Proceedings·P McMasterJ Bastos
Sep 2, 1998·Transplantation Proceedings·B D Kahan
Sep 2, 1998·Transplantation Proceedings·T MatsudaT Oka
Sep 2, 1998·Transplantation Proceedings·B D Kahan
Dec 5, 1998·Transplantation Proceedings·K SuzukiS Suzuki
Dec 5, 1998·Transplantation Proceedings·H YanK Hiromitsu
Dec 29, 1998·Transplantation Proceedings·Y MiyataK Dohi
Mar 20, 1999·Transplantation Proceedings·K YuzawaK Fukao
Mar 20, 1999·Transplantation Proceedings·S KunikataT Kurita
Mar 20, 1999·Transplantation Proceedings·K YamashitaS Todo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis